title: Inhibition of axonal morphogenesis by nonlethal, submicromolar concentrations of methylmercury.
abstract: We investigated the effects of sublethal concentrations of the neurotoxicant methylmercury (MeHg) on the developmental progression of cultured neurons to the stage of axonal morphogenesis. Chick (E8) forebrain neurons in vitro develop axons by a stereotyped developmental sequence nearly identical to that of widely used rat hippocampal neurons, but at much less cost and difficulty. In this chick forebrain system, 40% of neurons develop long axons after 2 days in culture, and 80% have axons after 4 days. A single, 2-h exposure to 0.5 or 0.25 microM MeHg reduced the number of neurons developing axons to approximately half that of controls without causing significant cell death for at least 2 days after treatment. Although MeHg caused an immediate depolymerization of neuronal microtubules, after 1 day of recovery the microtubule array of MeHg-treated neurons was indistinguishable by immunofluorescent assay from that of untreated cells at equivalent development stages. Thus, the inhibition of axonal development by submicromolar concentrations of MeHg did not appear to be the direct effect of microtubule disassembly. Chelation of Ca(2+) during MeHg exposure appeared to exert a small immediate protective effect, as previously reported, but was itself toxic within 1 day after chelation. We suggest that this inhibition of axonal morphogenesis by acute, sublethal concentrations of MeHg may play a role in the developmental syndrome caused by environmental exposure to MeHg.
authors: Department of Physiology, Michigan State University, East Lansing, Michigan 48824, USA.
authors: S R
authors: SR
authors: Heidemann
authors: P
authors: P
authors: Lamoureux
authors: W D
authors: WD
authors: Atchison
mesh_terms: D000818:Animals; D001369:Axons / Q000648:ultrastructure*; D002118:Calcium / Q000378:metabolism; D002478:Cells, Cultured; D002614:Chelating Agents / Q000494:pharmacology; D002642:Chick Embryo; D004533:Egtazic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D008767:Methylmercury Compounds / Q000008:administration & dosage / Q000633:toxicity*; D008870:Microtubules / Q000187:drug effects / Q000648:ultrastructure; D009024:Morphogenesis; D009474:Neurons / Q000648:ultrastructure*; D016548:Prosencephalon / Q000166:cytology / Q000196:embryology; D013997:Time Factors
chemical_list: D002614:Chelating Agents; D008767:Methylmercury Compounds; D004533:Egtazic Acid; C025603:1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; D002118:Calcium